HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, will report second quarter financial results after the close of U.S. financial markets on Thursday, August 13, 2015. Bellicum management will host a webcast and conference call at 5:00 p.m. Eastern that day to discuss the financial results and provide a business update. To access the call, participants should dia
| < Prev | Next > |
|---|
